Clinical trial
A Double Blind Placebo Controlled Study of Cannabis Smoking in Inflammatory Bowel Disease
NCT01040910 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind Placebo Controlled Study of Cannabis Smoking in Inflammatory Bowel Disease
- Lead sponsor
- Meir Medical Center
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- January 31, 2010
- Completion date
- July 31, 2012
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease, ulcerative colitis